Keywords: novartis, sets, new, standard, atopic, dermatitis, topical

Novartis Sets A New Standard For Atopic Dermatitis

Article | 06 July 1998

Novartis' new topical immunosuppressant - SDZ ASM 981 - is as effectiveas potent steroids in the treatment of atopic dermatitis, but ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in